NPHLA Intelligence
Clinical Trial Watch
Trials NPHLA follows, synchronised from ClinicalTrials.gov. We flag what matters (new registrations, changes in status and newly posted results) and ignore routine record edits. Every therapy in a trial is investigational.
- Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
Throne Biotechnologies Inc.. Conditions: Alopecia Areata; Alopecia Totalis; Alopecia Universalis. Investigational — not approved for the use studied.
- Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE)
Assiut University. Conditions: Androgenetic Alopecia; Cicatricial Alopecia. Investigational — not approved for the use studied.
- AnteAGE Exosomes and PEARL Multiplier With Microneedling for Facial Skin Quality
Cellese Inc.. Conditions: Skin Aging; Skin Quality. Investigational — not approved for the use studied.
- AnteAGE Biosomes With Radiofrequency Microneedling for Facial Skin Rejuvenation
Cellese Inc.. Conditions: Skin Aging; Facial Rhytides; Skin Tone. Investigational — not approved for the use studied.
- Treatment for "Asymmetric Crying Facies"
Xiaolei Jin. Conditions: Hemifacial Microsomia; Facial Nerve Paralysis. Investigational — not approved for the use studied.
- Deep Brain Stimulation Surgery for Focal Hand Dystonia
National Institute of Neurological Disorders and Stroke (NINDS). Conditions: Dystonia; Focal Dystonia; Musician's Dystonia. Investigational — not approved for the use studied.
- A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Results posted 2026-09-25. Investigational — not approved for the use studied.
- Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy
Spaulding Rehabilitation Hospital. Conditions: Achilles Injuries Tendon; Achilles Tendinopathy (AT); Achilles Tendinitis, Left Leg; Achilles Tendinitis, Right Leg; …. Investigational — not approved for the use studied.
- ASSET: Autologous Fat Grafting for the Treatment of Chronic Tendinopathy
Weill Medical College of Cornell University. Conditions: Chronic Tendinopathy. Investigational — not approved for the use studied.
- Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome
Banu Erkal. Conditions: Sjogren Syndrome; Xerostomia; Exosome. Investigational — not approved for the use studied.
- Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- Effect of an Intraoperative Polynucleotide Injection on Scar Quality After Thyroidectomy
Dr. Lutfi Kirdar Kartal Training and Research Hospital. Conditions: Postoperative Surgical Scar; Scar; Scar Formation; Neck Scar. Investigational — not approved for the use studied.
- MINOX: Treatment of Androgenetic Alopecia in Men for 24 Weeks
Eurofarma Laboratorios S.A.. Conditions: Alopecia. Investigational — not approved for the use studied.
- Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA
Pelage Pharmaceuticals, Inc.. Conditions: Androgenetic Alopecia. Results posted 2026-09-22. Investigational — not approved for the use studied.
- Platelet-Rich Plasma for Peyronie's Disease
Herlev Hospital. Conditions: Peyronies Disease. Investigational — not approved for the use studied.
- Treatment of Peyronie's Disease With Platelet-Rich Plasma
Herlev Hospital. Conditions: Peyronies Disease. Investigational — not approved for the use studied.
- ENIGI: A European Network for the Investigation of Gender Incongruence
University Hospital, Ghent. Conditions: Physical and Psychological Evaluation of Hormonal Therapy in Transsexual Persons. Investigational — not approved for the use studied.
- AWAKEN: Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Pelage Pharmaceuticals, Inc.. Conditions: Androgenetic Alopecia. Investigational — not approved for the use studied.
- SERCABOT: Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
Centre Oscar Lambret. Conditions: Post-Mastectomy Neuropathic Pain Syndrome. Investigational — not approved for the use studied.
- OMERIC: Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
Centre Oscar Lambret. Conditions: Advanced Breast Cancer. Investigational — not approved for the use studied.
- Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Industrial Farmacéutica Cantabria, S.A.. Conditions: Androgenetic Alopecia; Female Pattern Baldness. Investigational — not approved for the use studied.
- Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
M.D. Anderson Cancer Center. Conditions: Recurrent Lung Non-Small Cell Carcinoma; Stage II Non-Small Cell Lung Cancer AJCC v7; Stage IIA Non-Small Cell Lung C…. Investigational — not approved for the use studied.
- Topical Rifamycin SV for Wound Healing After Sapphire FUE Hair Transplantation
Elif Asena KANTARCI. Conditions: Androgenetic Alopecia; Wound Healing. Investigational — not approved for the use studied.
- Effectiveness of Platelet-rich Plasma Treatment of Knee Osteoarthritis
Universidad Nacional de Entre Rios. Conditions: Knee Osteoarthritis. Investigational — not approved for the use studied.
- TrichoscopyDM2: Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination
Al-Azhar University. Conditions: Diabete Mellitus; Female Androgenetic Alopecia; Dermoscopy. Investigational — not approved for the use studied.
- Topical Multivitamin Serum for Skin Heath
Erevna Innovations Inc.. Conditions: Aesthetic. Investigational — not approved for the use studied.
- Acupuncture of Different Treatment Frequency in Chronic Plantar Fasciitis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences. Conditions: Plantar Fasciitis, Chronic. Investigational — not approved for the use studied.
- PLATINUM EU: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
Merz Aesthetics GmbH. Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibit…. Investigational — not approved for the use studied.
- PLATINUM US: A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States
Merz North America, Inc.. Conditions: Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholine Release Inhibit…. Investigational — not approved for the use studied.
- Botox in HS: Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa
University of Massachusetts, Worcester. Conditions: Hidradenitis Suppurativa (HS). Investigational — not approved for the use studied.
- A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
AbbVie. Conditions: Glabellar Lines. Investigational — not approved for the use studied.
- A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Wake Forest University Health Sciences. Conditions: Central Centrifugal Cicatricial Alopecia. Investigational — not approved for the use studied.
- KDKR26: Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
K. Kay Durairaj, MD, FACS, A Medical Corporation. Conditions: Androgenic Alopecia; Female Pattern Hair Loss; Hair Loss. Investigational — not approved for the use studied.
- AGA: PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study
Nanfang Hospital, Southern Medical University. Conditions: Androgenetic Alopecia (AGA). Investigational — not approved for the use studied.
- A Study to Investigate the Safety and Efficacy of YY003 in Adults With Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd.. Conditions: Moderate to Severe Glabellar Lines. Investigational — not approved for the use studied.
- MONA: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Apsen Farmaceutica S.A.. Conditions: Alopecia, Androgenetic. Investigational — not approved for the use studied.
- Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia
Activ'inside. Conditions: Androgenic Alopecia; Healthy Adult Male. Investigational — not approved for the use studied.
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
Chong Kun Dang Pharmaceutical. Conditions: Androgenetic Alopecia. Investigational — not approved for the use studied.
- Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia
Absci Pty Ltd.. Conditions: Androgenetic Alopecia (AGA); Healthy Volunteers - Male and Female. Investigational — not approved for the use studied.
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
Fujian Medical University Union Hospital. Conditions: Androgenic Alopecia. Investigational — not approved for the use studied.
- A Clinical Study to Evaluate the Efficacy and Safety of Ultra in Promoting Hair Regrowth
CynosureLutronic. Conditions: Androgenic Alopecia. Investigational — not approved for the use studied.
- Study to Assess Participant Satisfaction After Jawline and Neck Treatment
AbbVie. Conditions: Jawline and Neck Appearance. Investigational — not approved for the use studied.
- Botulinum Toxin Type A for Wound Healing After Laparoscopic Colectomy
Pham Ngoc Thach University of Medicine. Conditions: Surgical Wound Healing; Botulinum Toxin, Type A. Investigational — not approved for the use studied.
- BoTox Into the Sternocleidomastoid Muscles (SCM)
Boston Medical Center. Conditions: Neck Muscle Issue. Investigational — not approved for the use studied.
- AI-09 In Subjects With Glabellar Lines, GL-101
Eirion Therapeutics Inc.. Conditions: Glabellar Frown Lines. Results posted 2026-08-31. Investigational — not approved for the use studied.
- Impact of Dysport on PMFF Donor Scar
Vanderbilt University Medical Center. Conditions: Skin Cancer Excision Site; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma. Investigational — not approved for the use studied.
- Study of DWP450 in Japanese Subjects With Glabellar Lines
Daewoong Pharmaceutical Co. LTD.. Conditions: Glabellar Lines. Investigational — not approved for the use studied.
- MMP US P3 416: A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- Microneedling for Androgenic Alopecia: a Clinical Study
Taipei Medical University WanFang Hospital. Conditions: Androgenic Alopecia. Investigational — not approved for the use studied.
- EXO-MINO: Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia
Tanta University. Conditions: Androgenetic Alopecia; Exosomes. Investigational — not approved for the use studied.
- Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Conditions: Wrinkle; Glabellar Frown Lines; Glabellar Furrowing. Investigational — not approved for the use studied.
- Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
Global Aesthetics LLC. Conditions: Wrinkle. Investigational — not approved for the use studied.
- MMP US P3 417: A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
AbbVie. Conditions: Masseter Muscle Prominence. Investigational — not approved for the use studied.
- Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
University of Florida. Conditions: Spasmodic Dysphonia. Results posted 2026-07-27. Investigational — not approved for the use studied.
- Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display
Al-Azhar University. Conditions: Excessive Gingival Display; Gingival Diseases; Gummy Smile; Esthetics, Dental. Investigational — not approved for the use studied.
- Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis
Peking University. Conditions: Facial Aging; Melomental Folds; Oral Commissure Ptosis. Investigational — not approved for the use studied.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Trial listings are not recommendations to enrol or prescribe.